Grifols (GRFS) Selling, General & Administrative (2011 - 2018)
Grifols (GRFS) Selling, General & Administrative (2011 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 3.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 5.65 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 1.75 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 1.92 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 3.41 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | -2.95 Bn |
| 10 | Grifols | 5.45 Bn | 4.45 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | -698.43 Mn |
| Jun 30, 2017 | 252.91 Mn |
| Dec 31, 2016 | 1.45 Bn |
| Sep 30, 2016 | 196.59 Mn |
| Jun 30, 2016 | 222.32 Mn |
| Dec 31, 2015 | 222.71 Mn |
| Sep 30, 2015 | 201.39 Mn |
| Jun 30, 2015 | 208.17 Mn |
| Mar 31, 2015 | -185.09 Mn |
| Dec 31, 2014 | 203.92 Mn |
| Sep 30, 2014 | 226.61 Mn |
| Jun 30, 2014 | 230,367.44 |
| Mar 31, 2014 | 217.83 Mn |
| Dec 31, 2013 | 203.07 Mn |
| Sep 30, 2013 | 182.22 Mn |
| Jun 30, 2013 | 180.81 Mn |
| Mar 31, 2013 | 175.97 Mn |
| Dec 31, 2012 | 189.38 Mn |
| Sep 30, 2012 | 163.37 Mn |
| Jun 30, 2012 | 175.55 Mn |